Publications in other proceedings
-
GeneReg 2025
GENETIC POLYMORPHISMS IN THE VDR GENE AND THEIR INFLUENCE ON NATALIZUMAB RESPONSE IN MULTIPLE SCLEROSIS PATIENTS
-
FRONTIERS 2024
FCGR2A variant rs1801274 as a Pharmacogenetic Predictor of Natalizumab Therapeutic Failure in Multiple Sclerosis Patients
-
FRONTIERS 2024
TLR4 genetic variants in the interface between gut-brain axis and Natalizumab response in Multiple Sclerosis patients.
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
